Chlorpromazine Induced Cataract in a female patient: A Case Report
Abstract
Tablet Chlorpromazine is a commonly used, affordable antipsychotic in developing countries. Chlorpromazine induced cataract and corneal pigmentation was first described by Greiner & Berry in 1964 but in the context of Nepal, there is no available literature or cases reported to date. Despite having a myriad of side effects, it is still used frequently in developing countries due to its cost-effectiveness. In this light, we report a case of a 43-year-old female with a diagnosis of Schizophrenia who had been treated with Tab. Chlorpromazine for 25 years. She lost to follow-up and presented at the OPD with cataract in bilateral eyes.
How to Cite
Thapa, N. R., Karki, D., Shrestha, A., & Singh, P. M. (2022). Chlorpromazine Induced Cataract in a female patient: A Case Report. Journal of Psychiatrists’ Association of Nepal, 11(2), 49-51. https://doi.org/10.3126/jpan.v11i2.57688
License
Copyright (c) 2022 Journal of Psychiatrists' Association of Nepal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
